Treace CEO buys 115,520 shares in open market
Treace Medical Concepts CEO John T. Treace increased his stake by buying 115,520 shares of common stock in open-market transactions.
Rhea-AI Filing Summary
Treace Medical Concepts CEO John T. Treace increased his stake by buying 115,520 shares of common stock in open-market transactions. The purchases occurred on May 26, 27, and 28, 2026 at weighted average prices of about $2.79, $2.87, and $3.02 per share, respectively. After these direct purchases, he held 7,273,833 common shares, which include 542,784 restricted stock units. He also reports additional indirect holdings through trusts and his spouse, while expressly disclaiming beneficial ownership of those indirectly held shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 61,202 | $3.0199 | $185K |
| Purchase | Common Stock | 49,810 | $2.8747 | $143K |
| Purchase | Common Stock | 4,508 | $2.7897 | $13K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (6)
- F1. The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $2.7600 to $2.8000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
- F2. Includes 542,784 restricted stock units.
- F3. The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
- F4. The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $2.7976 to $2.9400 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
- F5. The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $2.8233 to $3.1150 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
- F6. The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as trustee or co-trustee.
Key Figures
Key Terms
open-market purchase financial
restricted stock units financial
beneficial ownership financial
weighted average purchase price financial
indirect ownership financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did TMCI CEO John T. Treace report?
Does the TMCI CEO have indirect holdings, and how are they treated?
What do the weighted average prices in the TMCI Form 4 mean?
AI-generated analysis. How Rhea-AI works. Not financial advice.